1. Introduction
The world was hit in December 2019 by a severe acute respiratory syndrome (SARS), which began in Wuhan, China. The disease was rapidly named, and was further qualified as a global pandemic by the World Health Organization (WHO) in March 2020 [
1]. Recent data suggest that over 6.5 million people, including around 1935 in Cameroon, have died from COVID-19 since 2019 [
1]. The first case of COVID-19 was registered in Cameroon on the 6 March 2020, and the government adopted a nationwide strategic plan to address the situation [
2,
3]. The specific COVID-19 transmission mode led to the establishment of barrier measures, including lockdowns, social distancing, widespread stay-at-home orders, isolating suspected cases, quarantining confirmed cases, face masks, and health education on handwashing and environmental hygiene measures in order to control its propagation [
4]. Although the strategy proved to be effective in limiting the spread in China and Europe, the effect was very low in Cameroon due to non-observance of these restrictive measures [
5]. Based on these reasons, anti-COVID-19 vaccination could be viewed as the best option for African populations to prevent the effects of the virus.
Drug development obeys well-established rules, and it requires a long period to follow adequate steps. COVID-19 vaccination broke the record as the most promptly and massively deployed public health intervention in the history of healthcare [
6]. The WHO planned to achieve a vaccination rate of 70% by June 2022. For African countries, a two-step strategy was adopted by at least 10% of the population by September 2021 and 70% by June 2022 [
6]. The vaccination campaign was launched in Cameroon on 12 April 2021 with the objective of achieving a 60% vaccination rate in the population by December 2022 [
7]. A total of 840 vaccination centers were set up across the country, and four types of vaccines, including BBIBP-CorV (Sinopharm), ChAdOx1, nCoV-19 adenoviral (AZD1222; Oxford- Astra Zeneca), JNJ-78436735 (Ad26.COV2. S; Johnson and Johnson), and BNT162b2 mRNA (Pfizer Biontech), were mobilized through facilitation platforms, such as the COVID-19 Vaccines Global Access initiative [
7,
8]. On 13 February 2022, the Expanded Program of Immunization of the Cameroon Ministry of Public Health reported that only 2.9% of the general population, of which 5.87% were of the target population, were vaccinated [
7]. This figure is consistent with several reports which indicated that during the early stage of vaccination, contrary to 66.53% and 74.47% of COVID-19 vaccine acceptance rates in Burkina Faso and Nigeria, respectively, only 15% of Cameroonians were likely to take the vaccine [
4,
9]. With a 6% vaccination rate in September 2022, the West Region was far lower than the targeted rate [
7,
10]. This situation stresses the need to identify and monitor the factors limiting COVID-19 vaccination.
Vaccine hesitancy is defined as the reluctance or refusal to take the vaccine despite accessibility [
11]. Even if some studies have reported misinformation, mistrust of vaccine safety and effectiveness, and religion as just some of the factors associated with COVID-19 hesitancy, vaccine hesitancy is a context-dependent phenomenon that should be examined and monitored regarding local reality [
4,
12,
13]. Previous studies have reported that in Cameroon, the lack of confidence in approved vaccines as well as concerns about vaccine side effects were associated with vaccine hesitancy amongst health personnel [
6,
14]. Still, no community-based study, to the best of our knowledge, has investigated the reason for COVID-19 vaccine refusal in Cameroon in general. In order to address this question, this study investigated the determinants of COVID-19 vaccine hesitancy in the Menoua Division, West Cameroon.
4. Discussion
The present study evaluated factors associated with COVID-19 vaccine refusal in the Menoua Division from March to April 2022. A community-based cross-sectional and analytical survey was conducted, and a representative sample size of 520 participants were interviewed. Since the homologation of vaccines as the principal preventive approach to COVID-19, the WHO and governments around the world have faced many challenges to equitably distribute the vaccines [
4]. Despite the effectiveness of many strategies that have been put in place to facilitate the distribution of the vaccines in Africa [
7], an unpredicted resistance of the population to get vaccinated has been noticed [
4,
13]. As documented by other studies, many theories could explain this controversy, and factual evidence has pointed to poor information or misinformation as the major factors that spark fears of potential side effects of the vaccines [
6,
14,
16].
Participants of the present study were mostly from Dschang, Penka-Michel, and Nkong-Ni due to the high demography of these subdivisions. Males represented 60.58% of the participants, and 54.81% of the participants were married; the latter merely reflects national statistics, where about 50% of people aged between 15 and 49 years old are married [
17]. The study population was young, with a mean age of 33.27 ± 12.78, and with extremes of age from 18 to 96 years old. Only 11.15% of the participants were above 50 years old. The mean age of the participants was higher than the figure of the general population in Cameroon, and it was similar to the study population described by Aseneh et al. [
14]. A secondary education level was the most prevalent in the sample, and traders as well as people from the educational and informal sectors were the dominant professions. The profile of our participants was similar to that of the population studied in Kenya by Shah et al. [
18]. The high proportion of participants from the informal sector could be explained by the fact that the survey was conducted at the local market, while the frequency of teachers could reflect their readiness to participate in the survey due to their intellectual level. Indeed, Dinga et al. also reported teachers as the most represented category in their survey [
16]. As a consequence of the collection site, health personnel accounted for only 4.04% of the sample.
As the awareness and accessibility of a product can highly influence the decision of patients or candidates [
13], we evaluated the knowledge of participants regarding COVID-19 manifestations, prevention, and vaccination. Data revealed that participants had good knowledge of COVID-19 symptoms, and that this was significantly associated with gender, age, and education level. Despite the hesitancy of the population in respecting both barrier measures and the vaccination instructions to counter the pandemic, COVID-19 remains an important matter of concern across all social categories [
5]. This awareness could be the result of several sensitization campaigns held by sanitary authorities, which were a result of the government’s response strategy against COVID-19 [
7]. Contrary to COVID-19 manifestations, participants showed average knowledge (72.31%) regarding prevention of the virus, and many participants preferred medicinal plants, such as ginger, lemon, garlic, and artemisia as treatment options. The limited awareness of COVID-19 prevention is consistent with the limited respect that was shown towards the preventive methods observed nationwide [
5,
18,
19]. For some, the pandemic has already passed, and for others, COVID-19 is not dangerous and/or does not exist in Cameroon [
20].
Medicinal plants have long been used in Africa for health problems. This is not only sustained by cultural habits but also due to limited and affordable health services [
12,
20,
21]. Contrary to gender and education level, plant use was significantly associated (
p < 0.005) with age, as the preference for the use of plants increased with age. The effectiveness of medicinal plants has been scientifically discussed [
21,
22].
The evaluation of the knowledge/attitude of participants regarding vaccines revealed poor awareness of the participants of vaccination centers and the role of vaccines. They also claimed to be very worried about the side effects of the vaccines, which included, among others, cancer, sterility, and death. These data reflect the disinterest of the population towards vaccination, and they indicate how far conspiracy theories have found a fertile ground in Africa, where people are naturally reluctant to undergo some treatments [
20]. Since the beginning of the pandemic, misinformation has been shared on social media that claims COVID-19 is a planned strategy nefariously designed to control the world population, especially in Africa [
20,
23]. This thesis gained massive attention when the WHO predicted on 17 April 2020 that Africa would become the next epicenter of the COVID-19 pandemic [
24]. A similar refractory attitude to the one we have reported towards the COVID-19 vaccines was reported in Cameroon by Ajonina-Ekoti et al. before the vaccination campaign, where about 87% of the 591 participants reported their unwillingness to receive a COVID-19 vaccine if it was available in the country [
25]. Almost all of the participants ignored the role of vaccines, as 92.31% said that the vaccine prevent contamination. Unlike other vaccines, COVID-19 vaccines do not protect against infection, but, rather, prevent against severe forms of the pathology [
26]. Similarly, many people believe that medicinal plants have been proven to prevent severe forms and death from COVID-19 [
21,
22].
Data on the knowledge and attitude of populations regarding COVID-19 prevention and vaccination were a sign of the low vaccination rate in the population. Indeed, only 10% of our study population were vaccinated. Although higher than the data found in the West African regional and national statistics, this result is far lower than the mooted 70% by June 2022 and the 60% by December 2022 that were planned by the WHO and the Cameroonian government, respectively [
8,
10]. These results are consistent with the reports of Patwary et al. [
9] and Ajonina-Ekoti et al. [
25], which indicated that at the early stage of the vaccination campaign, contrary to the 66.53% and 74.47% of people that favored vaccination in Burkina Faso and Nigeria, respectively, only 15% of Cameroonians had declared that they were likely to take the COVID-19 vaccine. These data also corroborate the reports from Drescher et al. [
20], which indicated that both Cameroonians and Ivorians expressed reluctance to vaccinate right before the vaccination campaigns began. Furthermore, Murewanhema et al. [
27] suggested that ignorance sustains a limited acceptance of vaccines in Zimbabwe. In this study, participants were not questioned on the number of doses of the vaccine that were taken, and this information could have permitted us to differentiate participants that were partially vaccinated from those with full protection.
In respect to the objective of the present study, the vaccine status of participants was paired to some variables, and it appeared that the lack of information, the lack of safety or the lack of confidence regarding vaccines, as well as some sociodemographic features were all significantly associated with vaccine acceptance. These features have also been documented in numerous studies in Cameroon and Africa [
13,
16,
21].
Lack of information as a major factor affecting vaccine refusal was evidenced in this study by a significant association (
p < 0.005) between vaccine status and ignorance of the presence of COVID-19 in Cameroon, as well as ignorance of the availability of vaccines, vaccination centers, and the cost of the vaccines. These associations were strengthened by logistic regression, which indicated that participants who were not aware of vaccination points were about five times more likely to not be vaccinated compared to others (add ratio: 5.18). Moreover, none of the participants who were unaware that the vaccines are available in Cameroon and are free of charge were vaccinated. Data collection for this study occurred in late April and March 2022 during the first vaccination campaign. A total of 840 vaccination centers were deployed, and a vast sensitization campaign was held with the objective of providing adequate information to at least 90% of the population [
7,
8]. Our results could signify that these targets were not met or that participants deliberately ignored vaccination centers in order to mark their vaccine hesitancy.
The lack of confidence towards COVID-19 vaccines was expressed by a significant association between beliefs about vaccine quality and deadly side effects, and, as a result, a preference for medicinal plants as a treatment option. In accordance with the conspiracy theory on the agenda of limiting the African population [
20,
25,
28], 197 (37.88%) participants claimed that the vaccines were of bad quality, and 190 (36.54%) named potential severe side effects of vaccines, including gynecological cancer, sterility and death. None of the participants using the medicinal plants were vaccinated. The mistrust of vaccine quality has been reported as a leading factor towards vaccine hesitancy in many studies [
29]. Our findings are also in accordance with the ideas that a high vaccine hesitancy rate is observed in people using medicinal plants or complementary medicines [
12,
30,
31]. Considering the attitude towards COVID-19 vaccination, many researchers have focused on the curative potential of some medicinal plants against COVID-19 infection, and promising results have been revealed [
32].
In our study, age and education level were also found to be significantly associated with vaccine acceptance. As older persons are more likely to be victims of COVID-19 complications, younger participants were less interested in the vaccines [
33]. In contrast to those participants with primary and university education level, those with secondary education level were proportionally less vaccinated. Participants with a low level of education could be less exposed to social media and, thus, to misinformation, but this hypothesis was not verified in this study. These findings contrast with a study in France where participants with the lowest education level were more likely to refuse vaccines than other groups [
34]. This study did not investigate the profession or the specific health personnel regarding their vaccination status, but many studies have reported disparities in vaccine acceptance among health personnel in Cameroon and abroad [
6,
35,
36]. The investigation of this parameter in association with a patient’s decision to get vaccinated could help to provide in-depth information on the role of health personnel in vaccination coverage.